[{"_id":"project-settings","settings":{"translateMetaTags":true,"translateAriaLabels":true,"translateTitle":true,"showWidget":true,"isFeedbackEnabled":false,"fv":1,"customWidget":{"theme":"custom","font":"rgb(163, 163, 163)","header":"rgb(255, 255, 255)","background":"rgba(255, 255, 255,0.8)","position":"right","positionVertical":"bottom","border":"rgb(163, 163, 163)","borderRequired":true,"widgetCompact":true,"isWidgetPositionRelative":false},"widgetLanguages":[{"code":"ar","name":"العربية"},{"code":"de","name":"Deutsch"},{"code":"es-LA","name":"Español (América Latina)"},{"code":"fr","name":"Français"},{"code":"it","name":"Italiano"},{"code":"ja","name":"日本語"},{"code":"ko","name":"한국어"},{"code":"pt","name":"Português"},{"code":"zh","name":"中文(简体)"}],"activeLanguages":{"ar":"العربية","de":"Deutsch","es-LA":"Español (América Latina)","fr":"Français","it":"Italiano","ja":"日本語","ko":"한국어","pt":"Português","zh":"中文(简体)","en":"English"},"enabledLanguages":["ar","de","en","es-LA","fr","it","ja","ko","pt","zh"],"debugInfo":false,"displayBranding":true,"displayBrandingName":false,"localizeImages":false,"localizeUrls":false,"localizeImagesLimit":false,"localizeUrlsLimit":false,"localizeAudio":false,"localizeAudioLimit":false,"localizeDates":false,"disabledPages":[],"regexPhrases":[],"allowComplexCssSelectors":false,"blockedClasses":false,"blockedIds":false,"phraseDetection":true,"customDomainSettings":[],"seoSetting":[],"translateSource":false,"overage":false,"detectPhraseFromAllLanguage":false,"googleAnalytics":false,"mixpanel":false,"heap":false,"sdkAnalytics":true,"disableDateLocalization":false,"ignoreCurrencyInTranslation":false,"blockedComplexSelectors":[]},"version":146029},{"_id":"en","source":"en","pluralFn":"return n != 1 ? 1 : 0;","pluralForm":2,"dictionary":{},"version":146029},{"_id":"outdated","outdated":{"#Qualified healthcare providers can create an account seamlessly through the MosaicDX portal. Check out our How to Order section for a":1,"#How can a practitioner open a MosaicDX account? - MosaicDX":1,"#Modulo di richiesta di annullamento":1,"#3 test ordinati
Sconto del 15% sul":1,"#2 test ordinati
Sconto del 10% sul":1,"#Benzene Risk":1,"#Collection Instructions Urine – Kryptopyrrole and Porphyrins Test Kit Contents Start by identifying these elements of your test kit. If you are missing or have expired components, contact Mosaic Customer Service at 800-288-0383. Test kit box Silver thermo bag Ice pack (place flat in freezer immediately) Clear biohazard zip-lock bag Absorbent packing sheet Amber […]":1,"#Porphyrins Test Sample Collection Instructions":1,"#Collection Instructions Urine – Kryptopyrrole Test Kit Contents Start by identifying these elements of your test kit. If you are missing or have expired components, contact Mosaic Customer Service at 800-288-0383. Test kit box Silver thermo bag Ice pack (place flat in freezer immediately) Clear biohazard zip-lock bag Absorbent packing sheet Amber vial Collection cup […]":1,"#Kryptopyrrole Test Sample Collection Instructions":1,"#Kryptopyrrole Test Sample Test Report":1,"#[…] Total Fix 2807-05 (Black top vial) Gi360 Microbiome Profile SDS Stool kit MCC Total Fix 2805-05 (Yellow top vial) IgG Food MAP with Candida + Yeast Dried Blood Spot (DBS) = SDS DBS Mfg catalog AND SDS Lancets Serum = SDS Serum kit Kryptopyrrole SDS L-Ascorbic Acid Metals – Toxic + Nutrient Stool SDS Stool kit MCC Total Fix 2805-05 (Yellow top vial) Microbiology Test SDS Microbiology Profile Omega 3 Index […]":1,"#[…] Cambodia, China, Egypt, Greece, Japan, Lebanon, Mexico, Morocco, New Zealand, Nigeria, Pakistan, Panama, Peru, Philippines, Saudi Arabia, South Africa, South Korea, Ukraine, Venezuela Eligible testing: All excluding Kryptopyrrole and Amino Acids Plasma Patient Pay Choose this Option: If you are a patient who plans to pay for testing yourself, you have the option to […]":1,"#[…] Not all testing can be filed through insurance. MosaicDX is unable to provide CPT codes for the following tests. TOXDetect Profile® DNA Methylation Pathway Profile Glyphosate Test Kryptopyrrole Test If the patient’s test is covered by their insurance, any reimbursement will be sent directly to the patient from their insurance carrier. Key steps to file […]":1,"#The Kryptopyrrole Test measures the level of kryptopyrrole in urine. When high levels of kryptopyrrole a neurotoxin circulate in the body, it binds with Vitamin B6 and zinc causing them to be depleted faster and preventing their use in the brain and body. A high incidence of this is demonstrated in Autism Spectrum Disorders, ADHD, […]":1,"#Found 7 results for Kryptopyrrole Test":1,"#Trichotillomania Archives - MosaicDX":1,"#Tag: Trichotillomania":1,"#Tag: DNA Signature – Mind & Mood":1,"#DNA Signature - Mind & Mood Archives - MosaicDX":1,"#Children with ASD and related special needs presentations often have overlapping gastrointestinal, mitochondrial, nutrient, and redox-related physiology that may not be apparent from symptoms alone.[1,2,8,13,19]  The Organic Acids Test (OAT) is a pattern-based assessment looking at imbalances that can support clinical reasoning by identifying metabolite trends associated in the literature with dysbiosis, altered energy metabolism, and […]":1,"#Konstantynowicz J, et al. A potential pathogenic role of oxalate in autism. 2012. PMID: 21911305.":1,"#Chauhan A, et al. Modifiable nutritional biomarkers in autism spectrum disorder. 2025. PMC12072606.":1,"#Cascavita L, et al. Vitamin B12 and autism spectrum disorder: A review. 2025. PMID: 40218978.":1,"#Frye RE. The biochemistry of autism. 2024. DOI: 10.5772/intechopen.1006869.":1,"#Kern JK, et al. A clinical trial of glutathione supplementation in autism spectrum disorders. 2011. PMC3628138.":1,"#James SJ, et al. One carbon metabolism disturbances and the C677T MTHFR variant in autism. 2008. PMC4496129.":1,"#James SJ, et al. Differential one-carbon metabolites among children with autism spectrum disorder. 2024. DOI: 10.1016/j.tjnut.2024.09.019.":1,"#Reed MC, et al. Mathematical modeling of the methionine cycle and transsulfuration pathway in autism spectrum disorder. 2016. PMC5293619.":1,"#Mottron L, et al. Relationships between brain activity, tryptophan-related metabolites and autism spectrum disorder. 2025. DOI: 10.1038/s41467-025-58459-1.":1,"#Carpita B, et al. Does the kynurenine pathway play a pathogenic role in autism spectrum disorder? 2024. PMC11387593.":1,"#Frye RE, Rossignol DA. Examining autism spectrum disorders by biomarkers. 2012. PMC3672055.":1,"#Kaucka K, Zapliska A. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. 2011. PMID: 21300048.":1,"#Siddiqui MF, et al. Mitochondrial dysfunction in autism spectrum disorders. 2016. PMC5137782.":1,"#Hao Y, et al. Urine organic acids as potential biomarkers for autism spectrum disorders. 2019. PMC6502994.":1,"#Ding HT, et al. Clostridium bacteria and autism spectrum conditions: A systematic review and meta-analysis. 2018. PMC6024569.":1,"#Shaw W. Inhibition of the beta-oxidation pathway of fatty acids and Clostridia bacteria in autism. 2023. PMC10289112.":1,"#Fattorusso A, et al. The impact of gut microbiota-derived metabolites in autism spectrum disorder. 2021. PMC8470471.":1,"#Mangiola F, et al. Autism spectrum disorders and the gut microbiota. 2019. PMC6471505.":1,"#Sanctuary MR, et al. The gut microbiota and dysbiosis in autism spectrum disorders. 2018. PMC6855251.":1,"#Frye RE, et al. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis. 2024. PMID: 38703861.":1,"#Repeating a pattern-based metabolite assessment can support longitudinal clinical reasoning when dietary, antimicrobial, nutrient, or environmental interventions are being evaluated. [7,9,16] ":1,"#Response monitoring:":1,"#Results may inform whether stool, nutrient, toxicant, mitochondrial, or broader clinical history review should be prioritized next. [2,5,13,17] ":1,"#Follow-up planning:":1,"#Published literature suggests physiologic heterogeneity within ASD, so metabolite patterns may help identify which mechanisms are most relevant for a given patient presentation. [1,8,11,19] ":1,"#Subgroup context:":1,"#OAT can help organize findings across microbial, mitochondrial, neurotransmitter, nutrient, and redox domains rather than relying on a single marker. [1,7,17] ":1,"#Urinary and plasma oxalate elevations have been reported in ASD cohorts, suggesting a possible contributory pattern in selected patients when interpreted alongside GI and nutrient context. [20]":1,"#Oxalate-related burden":1,"#B-vitamin and antioxidant pathway disruptions reported in ASD may help explain imbalances seen when intake, absorption, and metabolic demand are clinically relevant. [17,18,19]":1,"#Functional nutrient insufficiency":1,"#Methylation cycle and glutathione pathway differences reported in ASD cohorts provide context for interpreting pyroglutamate, methylmalonic, and related OAT markers as functional signals [13,14,15,16]":1,"#Methylation / transsulfuration stress":1,"#HPHPA-related dopamine-beta-hydroxylase inhibition and altered kynurenine pathway balance provide mechanistic models for how urinary metabolites may align with catecholamine and neuroinflammatory physiology. [5,10,11,12]":1,"#Neurotransmitter imbalance patterns":1,"#Systematic reviews and urinary organic acid studies describe associations between ASD and altered pyruvate, lactate, TCA intermediates, and beta-oxidation markers consistent with impaired energy metabolism. [1,8,9]":1,"#Mitochondrial dysfunction patterns":1,"#Clostridia-, yeast-, and broader microbiota-derived metabolites have been linked with altered gut-brain signaling and neurobehavioral features in ASD literature, supporting hypothesis generation around intestinal contributors. [2,3,4,5,6]":1,"#Gut dysbiosis / microbial overgrowth":1,"#In urinary organic acid patterns across microbial, mitochondrial, nutrient, and redox domains have been reported in the ASD research literature (case-control, review, and metabolomic studies); these finds are exploratory and not diagnostic. [1,7,9,19]":1,"#
May help contextualize environmental burden hypotheses when paired with history and other testing, especially when TCA and microbial patterns converge. [1,5,17]":1,"#Markers associated with fungal/mycotoxin-related patterns, mineral binding effects, or broader toxicant stress; OAT does not directly quantify toxicants or mycotoxins. [1,5,17]":1,"#Can support clinical reasoning around cofactor need when interpreted with imbalances assessed on the OAT. [17,18,19]":1,"#Functional signals related to B2, B5, B6, B12, vitamin C, and CoQ10-dependent pathways rather than direct dietary intake. [17,18,19]":1,"#Nutrient needs":1,"#May help contextualize methylation capacity, glutathione synthesis resilience, and redox burden discussed in ASD literature. [13,14,15,16]":1,"#Methyl donor and transsulfuration pathway intermediates influenced by B12, folate-related metabolism, glutathione demand, and redox stress. [13,14,15]":1,"#Can support pattern recognition around dopamine, norepinephrine, serotonin, and kynurenine pathway balance and cofactor needs.[5,10,11,12]":1,"#Downstream urinary metabolites of catecholamine and serotonin turnover, shaped by host metabolism and potentially by gut-derived metabolites such as HPHPA. [5,10,11]":1,"#May reflect altered energy production, TCA cycle stress, or fatty acid oxidation inefficiency associated in the literature with ASD subgroups.[1,8,9]":1,"#Physiologic demand, illness stress, and metabolic inefficiency can shift pyruvate, lactate, citric acid cycle intermediates, and beta-oxidation markers; these are endogenous functional markers rather than direct exposure markers. [1,8,9]":1,"#Mitochondrial Health / Energy Markers":1,"#May help contextualize dysbiosis-related metabolite output, gut-brain signaling, and neurotransmitter-related patterns observed in ASD literature [2,3,4,6]":1,"#Gut fermentation products from bacterial, yeast, and fungal activity; literature discusses clostridia-, Candida-, and Aspergillus-associated metabolites rather than a single external exposure source [2,4,5,6]":1,"#Children with overlapping sleep, attention, communication, sensory, and GI concerns where a broader metabolic snapshot may help organize next steps":1,"#Complex multisystem presentations:":1,"#Clinical concern for low glutathione resilience, methylation burden, or oxidative stress-related vulnerability":1,"#Redox or detoxification stress patterns:":1,"#Restricted eating, selective diets, or concern for functional B-vitamin, antioxidant, or cofactor need":1,"#Nutrient insufficiency questions :":1,"#Fatigue, poor stamina, regression after illness, or patterns consistent with impaired mitochondrial efficiency":1,"#Energy or endurance concerns:":1,"#Symptom shifts that may track with yeast, clostridia, or altered gut-brain signaling":1,"#Behavioral variability after foods or antimicrobials:":1,"#Constipation, diarrhea, bloating, foul-smelling stool, or variable bowel patterns that may suggest microbial or fermentation-related imbalance":1,"#GI complaints:":1,"#When to Consider Organic Acids Test (OAT)":1,"#The Organic Acids Test (OAT) is a pattern-based assessment looking at imbalances that can support clinical reasoning by identifying metabolite trends associated in the literature with dysbiosis, altered energy metabolism, and cofactor insufficiency.[1,4,7,14]":1,"#Children with ASD and related special needs presentations often have overlapping gastrointestinal, mitochondrial, nutrient, and redox-related physiology that may not be apparent from symptoms alone.[1,2,8,13,19] ":1,"#A pattern-based urine metabolite assessment that may
help contextualize gut, mitochondrial, nutrient, and
detoxification-related physiology in complex
neurodevelopmental presentations.":1,"#Many patients with memory problems, mood changes, or behavior concerns don’t get a clear answer from routine testing. Toxic metals like lead, mercury, and arsenic can affect how the brain works—disrupting focus, mood, and nerve signaling. [1,2,3,9] The Metals – Toxic + Nutrient Elements test may help contextualize whether a toxic metal burden should be […]":1,"#Rahbar MH, et al. Concentrations of Lead, Mercury, Arsenic, Cadmium, Manganese, and Aluminum in Blood and Urine and Associations with ASD. Environ Res. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8392432/":1,"#Arora M, et al. Early life metal exposure dysregulates cellular bioenergetics in children with regressive autism. Transl Psychiatry. 2020;10:242. https://www.nature.com/articles/ s41398-020-00905-3":1,"#Skalny AV, et al. Systematic review and meta-analysis links autism and toxic metals and provides new arguments for the role of toxic metals in the aetiology of autism. J Trace Elem Med Biol. 2017;43:181-189. https://pubmed.ncbi.nlm.nih.gov/28716727/ ":1,"#Geier DA, et al. Hair Toxic Metal Concentrations and Autism Spectrum Disorder Severity in Young Children. Int J Environ Res Public Health. 2012;9(12):4486-4497. https://pmc.ncbi.nlm.nih.gov/articles/PMC3546773/":1,"#Nicolescu R, et al. Heavy Metals and Trace Elements in Hair and Urine of a Sample of Arab Children with Autistic Spectrum Disorder. J Autism Dev Disord. 2010;40(6):744-751. https://pmc.ncbi.nlm.nih.gov/articles/PMC3391939/":1,"#Adams JB, et al. The Severity of Autism Is Associated with Toxic Metal Body Burden and Red Blood Cell Glutathione Levels. J Toxicol. 2013;2013:532640. https://news.asu.edu/ content/higher-levels-several-toxic-metals-found-children-autism":1,"#Rahbar MH, et al. Exposure to Inorganic Arsenic and Lead and Autism Spectrum Disorders. Chem Res Toxicol. 2019;32(9):1904-1919. https://pubs.acs.org/doi/10.1021/acs.chemrestox.9b00134":1,"#Baj J, et al. Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder. Int J Mol Sci. 2023;24(6):5487. https://pmc.ncbi.nlm.nih.gov/articles/ PMC10049423/":1,"#Bjørklund G, et al. Metal Profiles in Autism Spectrum Disorders: A Crosstalk between Oxidative Stress, Inflammation, and Synapse Development. Int J Mol Sci. 2022;23(24):16006. https://pmc.ncbi.nlm.nih.gov/articles/PMC9820494/":1,"#Fre RE, Cakir J, Rose s, et al. Eearly life metal exposure dysregulates cellular bioenergetics in children with regressive autism spectrum disorder. Transl Psychiatry. 2020;10(1):223.":1,"#Li Y, et al. Association between heavy metals exposure (cadmium, lead, arsenic, mercury) and child autistic disorder: a systematic review and meta-analysis. Front Pediatr. 2023;11:1169733. https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2023.1169733/full":1,"#When paired with history and symptoms, results may help prioritize exposure reduction, environmental investigation, and broader functional assessment [2,3,5]":1,"#Care plan prioritization:":1,"#Metal findings can support clinical reasoning around oxidative stress, neuroinflammatory burden, mitochondrial strain, and impaired detoxification capacity without implying diagnosis [3,4,6,10]":1,"#Mechanistic context:":1,"#Results may help organize conversation around likely household, dietary, water, occupational, or environmental sources that deserve follow-up [1,2,5]":1,"#Exposure pattern review:":1,"#Early-life metal exposure has been associated with altered mitochondrial respiration and glycolytic regulation in ASD-focused mechanistic work, supporting a bioenergetic context for interpretation [3,10]":1,"#Mitochondrial / bioenergetic dysfunction":1,"#Lead, mercury, cadmium, and related metals have been associated with inflammatory signaling, microglial activation, and blood-brain barrier effects that may help frame clinical complexity [3,4]":1,"#Heavy metals may deplete glutathione, increase reactive oxygen species, and amplify redox imbalance, which is relevant because oxidative stress has been repeatedly described in ASD biology literature [3,4,6]":1,"#Oxidative stress / redox burden":1,"#Prenatal and early-life exposure models suggest certain metals may interact with sensitive windows of brain development through oxidative, inflammatory, and bioenergetic pathways [2,5,10]":1,"#Neurodevelopmental vulnerability":1,"#Hair and urine metal patterns, including mercury, tin, tungsten, antimony, and thallium in some studies, have been associated with higher symptom scores or regression-related findings in subsets of children [6,8,10]":1,"#Regressive autism / symptom severity":1,"#Multiple systematic reviews and meta-analyses report associations between higher burdens of selected metals and ASD diagnosis or symptom severity, but the literature remains heterogeneous and non-causal [1,2,9]":1,"#Evidence is more limited for several panel metals in ASD-specific literature, but broader toxicology data may support their use in a comprehensive exposure review rather than as stand-alone markers [2]":1,"#Rare-earth, radioactive, and other specialty metals may reflect environmental, occupational, dietary, dental, medical, or household exposures depending on the element [2]":1,"#Comprehensive exposure panel":1,"#These analytes have shown elevated levels or severity correlations in selected ASD studies and may help contextualize broader toxic burden when interpreted alongside symptoms and exposure history [2,6,7,8,9,10]":1,"#Aluminum from food additives, cookware, antiperspirants, and some pharmaceuticals; antimony from flame retardants and PET plastics; nickel from jewelry, stainless steel, coins, and occupational exposure; thallium, tin, and tungsten from industrial emissions, electronics, metal alloys, and contaminated dust or water [2,6,7,8]":1,"#Additional metals with supportive ASD literature":1,"#These metals have the strongest associative evidence in ASD literature and have been linked with oxidative stress, neuroinflammation, mitochondrial dysfunction, neurotransmitter disruption, and altered metal handling or excretion patterns [1,3,4,5,9]":1,"#Lead from legacy paint, dust, older plumbing, soil; mercury from some seafood and dental or industrial sources; arsenic from private well water, rice, pressure-treated wood, and some pesticides; cadmium from tobacco smoke, batteries, pigments, and contaminated foods [1,2,5,9]":1,"#Core neurotoxic metals":1,"#Older housing, private well water, high rice intake, frequent seafood intake, tobacco smoke, industrial proximity, or caregiver occupational exposure can increase concern for metal exposure":1,"#High-likelihood exposure history:":1,"#When neurologic, behavioral, immune, and metabolic findings cluster without a clear driver, metals testing may help contextualize part of the overall toxic burden picture":1,"#Unclear multi-system presentation:":1,"#Attention changes, irritability, poor focus, or learning challenges may prompt consideration of neurotoxicant burden alongside other contributors":1,"#Persistent sensory or cognitive concerns:":1,"#Cases with suspected oxidative stress, glutathione depletion, or mitochondrial strain may benefit from a more complete exposure assessment":1,"#Complex redox or mitochondrial picture:":1,"#Loss of language, social, or adaptive skills may warrant broader environmental exposure review as part of clinical context":1,"#Behavioral or developmental regression:":1,"#The Metals – Toxic + Nutrient Elements test may help contextualize whether a toxic metal burden should be considered as one part of a broader clinical workup, especially when exposure history, symptom clustering, or regression raises concern. [1,2,3,4,9]":1,"#Many patients with memory problems, mood changes, or behavior concerns don’t get a clear answer from routine testing. Toxic metals like lead, mercury, and arsenic can affect how the brain works—disrupting focus, mood, and nerve signaling. [1,2,3,9]":1,"#A broader view of toxic metal burden that may help
contextualize neurodevelopmental complexity.":1,"#ASD is increasingly understood as a complex gene–environment condition in which individual detoxification capacity plays a central role.[1] Many children with ASD carry variants in UGT glucuronidation enzymes, CYP450 isoforms, and paraoxonase genes that reduce their ability to clear environmental chemicals, leaving them disproportionately vulnerable to body burden accumulation. [2,4]  The TOXDetect Profile measures urinary […]":1,"#Heilbrun LP, Palmer RF, Jaen CR, Svoboda MD, Perkins J, Miller CS. Maternal Chemical and Drug Intolerances: Potential Risk Factors for Autism and Attention Deficit Hyperactivity Disorder (ADHD). J Am Board Fam Med. 2015;28(4):461-470.":1,"#Hallmayer J et al. Twin study implicating gene–environment interaction in ASD. PubMed. https://pubmed.ncbi.nlm.nih.gov/28475976/":1,"#Mottram DS et al. Acrylamide neurotoxicity: mechanisms and developmental implications. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9561965/":1,"#ECHO Cohort. Early childhood phthalate exposures associated with ADHD behaviors in childhood and adolescence. https://pubmed.ncbi.nlm.nih.gov/38692176/":1,"#EPA. EPA research provides important information on health effects of perchlorate exposure. https://www.epa.gov/sciencematters/epa-research-provides-important-information-health-effects-perchlorate-exposure":1,"#The Conversation. From fireworks to iodine and IQ: the perchlorate connection. https://theconversation.com/from-fireworks-to-iodine-and-iq-the-perchlorate-connection-86595":1,"#Hossain MM et al. Dopaminergic toxicity of atrazine. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC1853311/":1,"#Bardullas U et al. Chronic atrazine exposure causes disruption of the dopaminergic system. Neurotoxicol Teratol. 2011. https://pubmed.ncbi.nlm.nih.gov/24561379/":1,"#Rowan University. Researchers find BPA links to autism, ADHD. https://today.rowan.edu/news/2023/09/researchers-find-bpa-links-to-autism-adhd.html":1,"#Autism.org. New research points to alterations in BPA excretion pathway in children with autism/ADHD. https://autism.org/new-research-points-to-alterations-in-bpa-excretion-pathway-in-children-with-autism-adhd/":1,"#Shelton JF et al. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides. BMJ. 2019;364:l962.":1,"#Duke Superfund. Organophosphate pesticides and autism. https://sites.nicholas.duke.edu/superfund/organophosphate-pesticides-and-autism/":1,"#MosaicDX. TOXDetect Panel Clinical Report Reference. MDX_Report_TOXDetect_ENG.pdf":1,"#Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry. 2014;4(2):e360. Published 2014 Feb 11. doi:10.1038/tp.2014.4":1,"#New Patterns ABA. Environmental causes and risk factors of autism. https://www.newpatternsaba.com/blog/environmental-causes-risk-factors-of-autism":1,"#Hallmayer J et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011. https://pmc.ncbi.nlm.nih.gov/articles/PMC3944636/":1,"#Main PAE, Angley MT, O’Doherty CE, Thomas P, Fenech M. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr Metab (Lond). 2012;9(1):35.":1,"#TOXDetect Profile complements genetic, metabolic, and functional assessments by providing actionable data on the environmental contributors that interact with neurodevelopmental genetic susceptibility.[16,3]":1,"#Adds an Environmental Lens to Neurodevelopmental Workup:":1,"#Results may help support clinical reasoning around detoxification interventions, such as glutathione precursors for VOC/vinyl chloride burden, iodine sufficiency assessment alongside elevated perchlorate, or sauna/perspiration approaches for phthalate reduction. [5,12] ":1,"#Informs Individualized Detoxification Support:":1,"#Elevated analyte results can guide clinicians in prioritizing specific exposure source modifications—such as dietary changes, water filtration, or product swaps—tailored to the individual patient’s burden profile. [5,15] ":1,"#Supports Targeted Exposure Reduction:":1,"#Acrylamide exposure has been associated with mitochondrial dysfunction, oxidative stress, and impaired BDNF/CREB signaling—biological mechanisms that converge with recognized neuropathological features of ASD. [15,5]":1,"#Mitochondrial & Oxidative Stress Burden":1,"#Atrazine reduces striatal dopamine via vesicular dopamine uptake interference—a mechanism directly relevant to ASD neurobiology—and has been associated with anxiety and social deficit phenotypes in animal models. [10,11]":1,"#Dopaminergic & Social Behavior Dysregulation":1,"#Perchlorate competitively inhibits thyroid iodide uptake, and maternal hypothyroidism during pregnancy has been epidemiologically linked to increased ASD and ADHD risk in offspring. [12,13]":1,"#Thyroid-Mediated Developmental Risk":1,"#Prenatal organophosphate exposure has been epidemiologically associated with a 60% increased likelihood of ASD diagnosis when mothers reside within one mile of treated agricultural fields during gestation. [6,7]":1,"#Neurodevelopmental Delay":1,"#Early childhood phthalate and BPA exposures have been associated with inattentive and hyperactive-impulsive ADHD behaviors, with effects especially pronounced in children with co-occurring ASD. [8,9,14]":1,"#ADHD & Attention Dysregulation":1,"#Cumulative toxic body burden interacting with impaired detoxification genetics—particularly UGT, CYP450, and glutathione pathways—represents the prevailing framework for gene–environment interaction in ASD; no single toxicant is established as causal. [2,3,4,16]":1,"#International Agency for Research on Cancer (IARC)-classified carcinogens; detoxified via epoxide hydrolase and glutathione S-transferase—enzymes functionally impaired in some children with ASD [4,5]":1,"#Sterilized medical equipment, tobacco smoke, industrial chemical manufacturing [4,5]":1,"#HEMA (Ethylene Oxide / Vinyl Chloride)":1,"#Central nervous system (CNS) toxins metabolized via CYP450 and glutathione conjugation—pathways frequently impaired in ASD; elevated oxidative stress and neuroinflammatory burden [4,5]":1,"#Vehicle exhaust, industrial emissions, tobacco smoke, solvent-based products, plastics manufacturing [5]":1,"#VOC Panel (Benzene, Styrene, Acrylonitrile)":1,"#Endocrine disruptors with estrogenic/androgenic activity; share hormonal disruption pathways relevant to neurodevelopment[5]":1,"#Personal care products, cosmetics, pharmaceuticals, food preservatives[5]":1,"#Parabens (Butylparaben)":1,"#Impairs neuronal migration; causes oxidative stress, mitochondrial dysfunction, and disrupted BDNF/CREB signaling—pathways implicated in ASD neuropathology [15]":1,"#High-temperature cooked starchy foods (french fries, chips, bread crust), cigarette smoke [15]":1,"#Acrylamide (NAE)":1,"#Anti-androgenic endocrine disruption associated with inattentive/hyperactive ADHD behaviors, especially pronounced in children with co-occurring ASD [14]":1,"#Flexible PVC products, personal care products, food packaging, IV tubing, flooring [3,14]":1,"#Phthalates (MEHP, MEOHP)":1,"#Competitively inhibits thyroid iodide uptake; maternal hypothyroidism linked to increased ASD/ADHD risk; EPA research confirms structural brain malformations in offspring [12,13]":1,"#Contaminated groundwater, fireworks residue, rocket fuel byproducts, some leafy vegetables [12,13]":1,"#Established dopaminergic neurotoxicant in animal models; associated with anxiety, social deficits, and hypothalamic–pituitary–gonadal axis disruption [10,11]":1,"#Drinking water and groundwater in Midwest agricultural regions; corn and sorghum crops [10,11]":1,"#Atrazine Mercapturate (AM)":1,"#Children with ASD show ~10% reduced glucuronidation efficiency for BPA; associated with neuroinflammation and disruption of sex steroid signaling [8,9]":1,"#Polycarbonate plastics, food can linings, thermal receipt paper, BPS-containing “BPA-free” products [8,9]":1,"#Bisphenols (BPA, BPS)":1,"#Prenatal exposure associated with up to 3.3-fold increased ASD risk; mechanism involves acetylcholinesterase inhibition disrupting cholinergic neurodevelopment [6,7]":1,"#Fruits and vegetables treated with chlorpyrifos, diazinon, or malathion; proximity to agricultural fields [6,7]":1,"#Organo-phosphate Pesticides (DEP)":1,"#Maternal organophosphate or perchlorate exposure during pregnancy has been epidemiologically linked to increased neurodevelopmental risk in offspring.":1,"#Prenatal or early-childhood toxicant exposure suspected:":1,"#Overlapping symptom clusters commonly reported alongside ASD that may reflect neurochemical dysregulation associated with toxicant exposure.":1,"#Sensory sensitivities, irritability, or sleep disruption co-occurring with neurodevelopmental concerns:":1,"#Phthalates and BPA have both been associated with inattentive and hyperactive-impulsive behaviors, particularly in children with co-occurring ASD.":1,"#Co-occurring ADHD, anxiety, or mood dysregulation in a neurodevelopmental context:":1,"#Sudden or gradual loss of previously acquired skills, increased repetitive behaviors, or communication regression without clear medical etiology.":1,"#Unexplained behavioral regression or developmental plateau:":1,"#Maternal chemical intolerance – a marker of heightened physiological reactivity – has been associated with elevated rates of ASD and ADHD in offspring.":1,"#Family or personal history of chemical sensitivity:":1,"#Child or patient with confirmed or evolving ASD diagnosis and known proximity to agricultural areas, industrial sites, or high-use pesticide regions.":1,"#Diagnosed or suspected ASD with environmental exposure history:":1,"#The TOXDetect Profile measures urinary metabolites of pesticides, plasticizers, industrial chemicals, and endocrine disruptors whose mechanistic pathways—dopaminergic disruption, thyroid axis interference, neuroinflammation, and oxidative stress—overlap substantially with recognized features of ASD neurobiology.[2,3] By identifying elevated chemical exposures, TOXDetect may help clinicians contextualize neurodevelopmental presentations and support individualized, evidence-informed intervention strategies.[4,15]":1,"#ASD is increasingly understood as a complex gene–environment condition in which individual detoxification capacity plays a central role.[1] Many children with ASD carry variants in UGT glucuronidation enzymes, CYP450 isoforms, and paraoxonase genes that reduce their ability to clear environmental chemicals, leaving them disproportionately vulnerable to body burden accumulation. [2,4] ":1,"#Revealing the environmental body burden
that may help contextualize
neurodevelopmental vulnerability.":1,"#Neurologic& Mental HealthClinical Testing Guide Uncovering powerful insights — helpingclinicians match the dominant presentation tothe most relevant testing lens. How Testing from Mosaic DiagnosticsSupports Clinical Insight Why We Need to Look Deeper Neurologic and mental health complaints often reflect overlapping biologic patterns rather than a single clear starting point or one single symptom. An integrated […]":1,"#Neurologic & Mental Health Clinical Testing Guide - MosaicDX":1,"#Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia. 2010;30(7):829-837.":1,"#Harding CF, et al. Mold inhalation causes innate immune activation and cognitive and emotional dysfunction. Brain Behav Immun. 2020;87:110-122.":1,"#Qian XH, Xu S, Sun L, et al. Mechanisms of short-chain fatty acids derived from gut microbiota in Alzheimer disease. Ageing Res Rev. 2022;78:101612.":1,"#Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53(10):1459-1464.":1,"#Karri V, Schuhmacher M, Kumar V. Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: a general review of metal mixture mechanism in brain. Environ Toxicol Pharmacol. 2016;48:203-213.":1,"#Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OP. Environmental neurotoxicity: mechanisms and pathophysiology. Annu Rev Pharmacol Toxicol. 2004;44:87-110.":1,"#Madison AA, Kiecolt-Glaser JK. Stressed to the core: inflammation and intestinal permeability in stress-related psychiatric disorders. Biol Psychiatry. 2024;95(8):635-646.":1,"#Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-312.":1,"#“The MycoTOX Profile showed multiple high mycotoxins — including Gliotoxin reporting over 3000 ng/g, with Sterigmatocystin and Aflatoxin M1 also well above acceptable range.”":1,"#GI issues, microbiome disruption & gut-immune connection":1,"#Cognitive Complaints / Brain Fog / Executive Function":1,"#The Myco-Metabolic Panel integrates the MycoTOX Profile™ with the Organic Acids Test (OAT), providing synergistic insights into toxic mold exposure and its negative impacts on critical bodily functions like energy production, detoxification, and nutrients.":1,"#Gastrointestinal Dysbiosis":1,"#Evaluates mycotoxin exposure via both inhalational and dietary routes. Many patients with a history of mold or water-damaged building exposure show up with a mix of symptoms—like brain fog, mood changes, fatigue, and sleep problems—that are hard to pin down to one cause.[1,2,3] Because these symptoms can overlap with stress, anxiety, or other common conditions, […]":1,"#Ehsanifar M, Gholami A, Pahnavar N, Shenasi R, Golmohammadi M. Exposure to mycotoxins: neurological disorders and psychiatric manifestations. OBM Neurobiol. 2026;10:1-21. doi:10.21926/obm.neurobiol.2601322.":1,"#Miller JD, McMullin DR. Fungal secondary metabolites as modulators of immune function. J Appl Microbiol. 2014;117(4):952-962.":1,"#Frohlich AA, et al. Neurochemical effects of mycotoxins: dopamine and serotonin pathways. Mycotoxin Res. 2015;31(3):127-140.":1,"#Malir F, Ostry V, Pfohl-Leszkowicz A, Novotna E. Ochratoxin A: 50 years of research. Toxins (Basel). 2016;8(7):191.":1,"#Pestka JJ. Deoxynivalenol-induced oxidative stress and immune modulation. Toxins (Basel). 2010;2(6):1300-1317.":1,"#Arce-Lopez B, et al. Biomonitoring of mycotoxins in patients with neurodegenerative diseases. Toxins (Basel). 2021;13(7):477.":1,"#Serrano-Civantos M, et al. Ochratoxin A and Parkinson’s disease: a systematic review of molecular and clinical evidence. Arch Toxicol. 2025.":1,"#Marin S, Ramos AJ, Cano-Sancho G, Sanchis V. Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem Toxicol. 2013;60:218-237.":1,"#Harding CF, et al. Mold inhalation causes innate immune activation and cognitive and emotional dysfunction. Brain Behav Immun. 2020;86:110-122.":1,"#Ehsanifar M, et al. Mold and mycotoxin exposure and brain disorders. J Integr Neurosci. 2023;22(6):137.":1,"#Multi-Route Exposure Assessment":1,"#Detection of specific mycotoxin classes may help contextualize biologically plausible mechanisms—including oxidative stress, mitochondrial dysfunction, and neuroimmune activation—that are relevant to the patient’s presenting symptom profile. [1,3,4,7,8]":1,"#Mechanistic Pathway Context":1,"#Adds mycotoxin data that may be considered alongside water-damaged, occupational, or food exposure history. [2,4,6,11]":1,"#Adds Exposure Context":1,"#Relapsing fatigue, and cognitive slowing associated with neuroimmune activation may be contextually supported by mycotoxin exposure data in patients with overlapping environmental triggers. [1,3,8,11]":1,"#Neuroinflammation, oxidative stress, and environmental toxin exposure represent emerging research areas in Alzheimer’s pathophysiology; mycotoxin biomonitoring may provide one biologic data point within a broader neurodegenerative clinical workup. [1,6,7,8]":1},"version":146029}]